SIX Swiss Exchange · Healthcare
Invest in Curatis stock from India
Indian and foreign residents can buy Curatis (CURN) shares directly through Paasa.
By Paasa · Updated
Curatis at a glance
- Price
- CHF 19.85+CHF 0.95 (5.03%)
- Market cap
- CHF 105.23M
- Day range
- CHF 18.40 – CHF 19.90
- P/E
- -156.18
- Dividend yield
- None
- Volume
- 2.50K
- 1 month
- +1.79%
- 6 months
- -15.89%
- YTD
- +65.42%
- 1 year
- +43.84%
- 5 years
- -94.32%
Curatis statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CHF 10.8M | CHF 6.9M | CHF 0.0 | CHF 0.0 | CHF 0.0 |
| Gross profit | CHF 2.8M | CHF 1.6M | CHF 0.0 | −CHF 1.5M | CHF 0.0 |
| Operating income | −CHF 1.5M | −CHF 3.3M | −CHF 16.3M | −CHF 5.2M | −CHF 410.0K |
| Net income | −CHF 1.4M | −CHF 4.3M | −CHF 49.4M | −CHF 34.7M | CHF 137.0K |
| Earnings per share | −CHF 0.28 | −CHF 1.49 | −CHF 176.38 | −CHF 221.63 | CHF 0.00 |
| EBITDA | −CHF 1.1M | −CHF 4.3M | −CHF 38.3M | −CHF 38.4M | −CHF 130.0K |
| Total assets | CHF 56.0M | CHF 55.5M | CHF 120.0K | CHF 14.0M | CHF 136.0K |
| Total debt | CHF 0.0 | CHF 0.0 | CHF 133.0K | CHF 3.0M | CHF 429.0K |
| Cash and short-term investments | CHF 1.9M | CHF 3.0M | CHF 9.0K | CHF 1.3M | CHF 124.0K |
| Shareholders' equity | CHF 46.1M | CHF 45.6M | −CHF 312.0K | CHF 6.8M | −CHF 400.0K |
| Operating cash flow | −CHF 1.3M | −CHF 825.0K | −CHF 1.9M | −CHF 4.7M | −CHF 359.0K |
| Free cash flow | −CHF 2.5M | −CHF 825.0K | −CHF 1.9M | −CHF 4.7M | −CHF 359.0K |
| Capital expenditure | −CHF 1.2M | CHF 0.0 | CHF 0.0 | −CHF 4.0K | CHF 0.0 |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CHF; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Merck KGaA | MRK.DE | €138.00 | €59.96B |
| Indivior Pharmaceuticals | INDV | $35.45 | $4.42B |
| Regencell Bioscience | RGC | $7.63 | $3.78B |
| Idorsia | IDIA.SW | CHF 4.08 | CHF 1.07B |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Curatis from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CHF when you buy.
Step 3
Search CURN and buy
Find Curatis by name or by its ticker, CURN, and place your order.
Why invest in Curatis from India
What Curatis does
Curatis Holding AG specializes in the entire lifecycle of pharmaceutical products, including the procurement, advancement, and market release of medications specifically designed for the diagnosis, prevention, and management of rare and specialized medical conditions. The company's extensive product offerings span a broad array of therapeutic areas. Curatis operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Curatis stock from India?
Yes. Indian residents and NRIs can buy Curatis (CURN) shares directly through Paasa. Curatis is listed on the SIX Swiss Exchange, in the Drug Manufacturers - Specialty & Generic industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Curatis shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CHF/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.